Gufic Biosciences | GUFICBIO | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
2,4933,0413,5083,5784,914
Cost of revenue
Cost of revenue
-1,208-1,422-1,808-1,775-2,503
Gross Profit
Gross Profit
1,285
1,619
1,700
1,803
2,411
Sales, general & ad...
Sales, general and administrative
-1,015-1,206-1,240-1,357-1,535
Depreciation
Depreciation and amortization
-37-43-46-84-163
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
0-32000
Operating income
Operating income EBIT
233
339
413
362
713
 
      
Profit before tax
Profit before tax
180295353303577
Net Income
Net income
114
160
219
229
442
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
1.48
2.07
2.82
2.94
4.56